“Translational Research in HIV and Substance Use Prevention and Care”
December 1, 2022 | 12:30 – 1:30 PM
Dr. David R. Holtgrave serves as the Assistant Director for Translational Research in the White House Office of National Drug Control Policy. Dr. Holtgrave previously served as the Dean of the University at Albany School of Public Health, where he also held the titles of State University of New York Distinguished Professor, SUNY Empire Innovations Professor, and tenured Professor of Health Policy, Management, and Behavior (he is currently on leave from the SUNY faculty while performing federal service). In addition, Dr. Holtgrave is an Adjunct Professor at the Johns Hopkins Bloomberg School of Public Health, Department of Health, Behavior & Society (a Department for which he previously served as the Founding Chair). Dr. Holtgrave’s three-decade career in public health has also included senior leadership positions at the US Centers for Disease Control and Prevention, Emory University and Johns Hopkins University, as well as serving as Vice-Chair of the Presidential Advisory Council on HIV/AIDS during President Obama’s administration. Dr. Holtgrave has conducted highly cited, rigorous research designed to inform important and timely public health policy and program questions. Dr. Holtgrave has taught research methodology to graduate students and delivered an award-winning course on “Translating Science into Public Health Programs” at both Emory and Johns Hopkins. Dr. Holtgrave’s work on substance use has included the publication of economic evaluations of sterile syringe service programs; cost analysis of HIV-related services for persons who inject drugs; examinations of the linkages between substance use and HIV treatment adherence among homeless persons living with HIV; use of national substance use related data sets to estimate HIV risk levels in the US; study of the prevalence of tobacco use and HIV status among persons who inject drugs; and cost-utility analyses of smoking cessation and prevention programs. A common theme throughout his work is fostering a multi-directional dialogue between program managers, policy makers, and applied researchers to support the translation of science into population-level impact and maximization of health equity.